Kush Parmar

Affiliations

  • Large Shareholder, Director at Entrada Therapeutics Inc. (TRDA), 2025-06-12
  • Large Shareholder at Camp4 Therapeutics Corp (CAMP), 2024-10-15
  • Large Shareholder at Skye Bioscience Inc. (SKYE), 2024-09-13
  • Large Shareholder at Artiva Biotherapeutics Inc. (ARTV), 2024-07-24
  • Director at Rallybio Corp (RLYB), 2024-05-17
  • Large Shareholder at Enliven Therapeutics Inc. (ELVN), 2024-02-16
  • Large Shareholder at Cincor Pharma Inc. (CINC), 2023-02-28
  • Large Shareholder, Director at Akouos Inc. (AKUS), 2022-12-02
  • Director at Homology Medicines Inc. (FIXX), 2022-06-17
  • Large Shareholder, Director at Vor Biopharma Inc. (VOR), 2022-06-16
  • Large Shareholder at Cabaletta Bio Inc. (CABA), 2021-11-03
  • Large Shareholder at Impel Neuropharma Inc (IMPL), 2021-04-30
  • Co-Ceo at 5:01 Acquisition Corp. (FVAM), 2020-12-01
  • Other at Aprea Therapeutics Inc. (APRE), 2020-10-08
  • Director at Arvinas Inc. (ARVN), 2019-09-26
  • Director at Scpharmaceuticals Inc. (SCPH), 2018-06-21
  • Director at Audentes Therapeutics Inc. (BOLD), 2018-06-08
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
TRDA $20.00 250,000 $5,000,000.00 1,132,357 2021-11-02 Filing
RLYB $13.00 615,384 $7,999,992.00 1,406,098 2021-08-02 Filing
VOR $18.00 444,444 $7,999,992.00 1,858,470 2021-02-09 Filing
VOR $18.00 111,111 $1,999,998.00 4,833,959 2021-02-09 Filing
AKUS $17.00 294,117 $4,999,989.00 1,094,101 2020-06-30 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
RLYB $8.20 100,000 $820,000.00 2,378,969 2023-03-07 Filing
RLYB $12.50 50,329 $629,112.50 1,251,755 2022-06-03 Filing
RLYB $12.50 99,671 $1,245,887.50 2,478,969 2022-06-03 Filing
RLYB $13.00 33,553 $436,189.00 1,302,084 2022-05-23 Filing
RLYB $13.00 66,447 $863,811.00 2,578,640 2022-05-23 Filing